Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Regulatory News (DCTA)

  • This share is currently suspended. It was suspended at a price of 6.75
  • There is currently no data for DCTA

Customer announcement

18 Oct 2016 07:00

RNS Number : 7616M
Directa Plus PLC
18 October 2016
 

18 October 2016

 

Directa Plus plc

("Directa Plus" or the "Company")

 

Notification of potential customer impairment

 

Directa Plus (AIM: DCTA), a producer and supplier of graphene-based products for use in consumer and industrial markets, has been made aware that a regional governmental grant awarded to a customer who acquired three decontamination units in 2015 for €1.0 million has been rescinded. The customer has notified the Company that it is now unable to satisfy the outstanding payments due. Accordingly, the Company and customer are in discussions to resolve the matter.

 

It is important to note that any potential impairment to the accounts would be a non-cash item and has no ongoing impact on Directa Plus' core business of sale of graphene materials.

 

Further announcements will be made as and when appropriate.

 

Giulio Cesareo, Chief Executive Officer of Directa Plus, said: "This news is clearly disappointing and we are exploring a range of scenarios with the customer to address this position. We will update the market as soon as we have better visibility on the situation and likely outcome of current discussions. However, we continue to view the environmental sector and our Grafysorber® product solution as a strong growth opportunity for the Company."

 

This announcement contains inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations

 

Enquiries

 

Directa Plus plc

Giulio Cesareo, CEO

Marco Ferrari, CFO

+39 02 36714458

Cantor Fitzgerald Europe (Nominated Adviser and Broker)

Marc Milmo, David Foreman, Michael Reynolds (Corporate Finance)

Mark Westcott, David Banks (Sales)

+44 20 7894 7000

Luther Pendragon (Financial PR)

Harry Chathli, Claire Norbury, Alexis Gore

+44 20 7618 9100

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDMMMGRNMGVZM
Date   Source Headline
31st Jan 20247:00 amRNSContract win with FORD Otosan
20th Dec 20237:00 amRNSAcquisition of groundbreaking technology
15th Dec 202311:44 amRNSExpansion of collaboration with Miguel Caballero
10th Nov 20237:00 amRNSChange of Nominated Adviser
27th Sep 20237:00 amRNSHalf-year Report
18th Sep 20237:00 amRNSStrategic collaboration with The SPECTRUM Group
8th Sep 20237:00 amRNSNotice of Interim Results
7th Sep 20237:00 amRNSSignificant contract secured with LIBERTY Galati
19th Jul 20237:00 amRNSProject tender awarded
29th Jun 20237:00 amRNSDirecta Plus receives two new Italian patents
22nd Jun 20237:00 amRNSNew concept for produced water decontamination
15th Jun 20235:40 pmRNSResult of AGM
8th Jun 20237:00 amRNSNew product launch
19th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
10th May 20237:00 amRNSFinal Results
9th May 20237:00 amRNSNew contract with customer Alfredo Grassi
27th Apr 20237:00 amRNSNotice of Results Presentations
20th Mar 20237:00 amRNSNew Patent Granted
27th Feb 20237:00 amRNSTrading Update and Notice of Results
21st Dec 20227:00 amRNSNew significant contract with Pigmentsolution
5th Dec 20222:05 pmRNSSecond Price Monitoring Extn
5th Dec 20222:00 pmRNSPrice Monitoring Extension
2nd Dec 20227:00 amRNSTrading Update
29th Nov 20227:00 amRNSGrant Award
21st Nov 20227:00 amRNSDirectorate Change
28th Oct 20227:00 amRNSFirst Commercial Contract in Latin America
21st Oct 20227:00 amRNSFirst Major Commercial Contract for Gipave
17th Oct 20227:00 amRNSBoar Changes
17th Oct 20227:00 amRNSBoard Changes
29th Sep 202211:05 amRNSSecond Price Monitoring Extn
29th Sep 202211:00 amRNSPrice Monitoring Extension
29th Sep 20227:00 amRNSHalf-year Report
1st Sep 20227:00 amRNSTrading Statement
30th Aug 20227:00 amRNSUS Patent Notice
4th Aug 20227:00 amRNSPartnership Extension and US Patent Award
19th Jul 20227:00 amRNSAgreement with REDA Energy for Grafysorber
5th Jul 20227:00 amRNSSupply Agreement
22nd Jun 20227:00 amRNSGrant of Italian Filtration Patent
17th Jun 20223:40 pmRNSResult of AGM
17th Jun 20227:00 amRNSAGM Statement
19th May 20227:00 amRNSPosting of Annual Report and Notice of AGM
5th May 20227:00 amRNSFinal Results
22nd Apr 20227:00 amRNSPartnership to Develop Automotive Fabrics
4th Apr 20227:00 amRNSUS EPA Authorises Grafysorber for Use in US
7th Mar 20227:00 amRNSOxfordshire Starts Second Trial of GiPave
28th Feb 20224:50 pmRNSExercise of Options
8th Feb 20225:20 pmRNSHolding(s) in Company
29th Dec 202111:11 amRNSResult of General Meeting & TVR
20th Dec 20217:00 amRNSGrant of EU Patent for Shoe Soles
10th Dec 20215:00 pmRNSPosting of Circular and Notice of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.